Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

The document reports termination of a Phase 1 study evaluating AMG 357 in females with rheumatoid arthritis, focusing on safety, tolerability, and activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AMG 357

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 1 | Status: TERMINATED